Anti-PERM/ MPO functional antibody

Anti-PERM/ MPO functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to MPO/MPO products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T23471-Ab-1/ GM-Tg-hg-T23471-Ab-2Anti-Human MPO monoclonal antibodyHuman
GM-Tg-rg-T23471-Ab-1/ GM-Tg-rg-T23471-Ab-2Anti-Rat MPO monoclonal antibodyRat
GM-Tg-mg-T23471-Ab-1/ GM-Tg-mg-T23471-Ab-2Anti-Mouse MPO monoclonal antibodyMouse
GM-Tg-cynog-T23471-Ab-1/ GM-Tg-cynog-T23471-Ab-2Anti-Cynomolgus/ Rhesus macaque MPO monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T23471-Ab-1/ GM-Tg-felg-T23471-Ab-2Anti-Feline MPO monoclonal antibodyFeline
GM-Tg-cang-T23471-Ab-1/ GM-Tg-cang-T23471-Ab-2Anti-Canine MPO monoclonal antibodyCanine
GM-Tg-bovg-T23471-Ab-1/ GM-Tg-bovg-T23471-Ab-2Anti-Bovine MPO monoclonal antibodyBovine
GM-Tg-equg-T23471-Ab-1/ GM-Tg-equg-T23471-Ab-2Anti-Equine MPO monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T23471-Ab-1/ GM-Tg-hg-T23471-Ab-2; GM-Tg-rg-T23471-Ab-1/ GM-Tg-rg-T23471-Ab-2;
GM-Tg-mg-T23471-Ab-1/ GM-Tg-mg-T23471-Ab-2; GM-Tg-cynog-T23471-Ab-1/ GM-Tg-cynog-T23471-Ab-2;
GM-Tg-felg-T23471-Ab-1/ GM-Tg-felg-T23471-Ab-2; GM-Tg-cang-T23471-Ab-1/ GM-Tg-cang-T23471-Ab-2;
GM-Tg-bovg-T23471-Ab-1/ GM-Tg-bovg-T23471-Ab-2; GM-Tg-equg-T23471-Ab-1/ GM-Tg-equg-T23471-Ab-2
Products NameAnti-MPO monoclonal antibody
Formatmab
Target NameMPO
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Diagnostic target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MPO benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T23471-Ag-1Recombinant multi-species PERM/ MPO protein


    Target information

    Target IDGM-T23471
    Target NameMPO
    Gene ID4353,17523,303413,714246,609986,100142673,511206,100070920
    Gene Symbol and SynonymsmKIAA4033,MPO
    Uniprot AccessionP05164
    Uniprot Entry NamePERM_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Diagnostics Biomarker
    DiseaseOvary Cancer, prolonged cough, Eosinophilic airway inflammation, lung function assessment, Asthma, Congenital occlusion of ureteropelvic junction, Dent disease, Cardiovascular disease, Cystic fibrosis
    Gene EnsemblENSG00000005381
    Target ClassificationN/A

    The target: MPO, gene name: MPO, also named as . Myeloperoxidase (MPO) is a heme protein synthesized during myeloid differentiation that constitutes the major component of neutrophil azurophilic granules. Produced as a single chain precursor, myeloperoxidase is subsequently cleaved into a light and heavy chain. The mature myeloperoxidase is a tetramer composed of 2 light chains and 2 heavy chains. This enzyme produces hypohalous acids central to the microbicidal activity of neutrophils. [provided by RefSeq, Nov 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.